ID    AVR/I/SSAP120
ET    Clinical
PN    P-113
PL    12 [Note: any special compound, if present in sequence, is not considered in length]
SR    Not available
SO    Synthetic peptide
TX    Not available
VL    Experimentally validated
XX
TO    VISA02 (clinical MDR strain isolate provided by Tsai-Ling Yang, National Health Research Institutes (Miaoli, Taiwan))
IC    MIC = 64 microG/ML
TH    P-113 exhibited increased toxicity at concentrations greater than 25 microG/mL, causing 10-20% cell death and hemolysis.
XR    PubMed: 32605123
XR    RCSB PDB/PDBsum/PDBe/PDBj/PDBe-KB/MMDB: Not available 
XR    UniProt: Not available
XR    DrugBank: DB06763
XX
SQ    SEQUENCE  
      Ac- A K R  His His G  Y K R K F  His -NH2 
//

